tirzepatide coffee interaction foods to avoid: the complete guide to eating smarter on GLP-1 therapy What to Drink on Tirzepatide:

141 They remain in the body, interacting with GLP-1 receptors in various organs, which could lead to DDIs through mechanisms of action such as slowing gastric emptying, reducing fat mass and inflammation, and increasing glomerular filtration rate (GFR) and renal plasma flow, consequently altering the pharmacokinetics of the victim drug (Figure 3)

Key Takeaways Bloating is linked to slower digestion Symptoms are most common early in treatment Meal size and timing affect bloating severity Severe bloating is uncommon Medical guidance reduces discomfort Why Zepbound Might Make You Feel Bloated Zepbound activates GLP-1 and GIP receptors

Some patients experience increased hunger in the 24-48 hours before their next weekly injection due to declining medication levels

Self-adjusting risks either underdosing (reducing effectiveness) or overdosing (increasing side effects and safety risks)

Some patients have reported billing issues

After one year of treatment, patients typically lose 20% or more of their body weight with Mounjaro (Tirzepatide)